tianeptine has been researched along with Fatty Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benet, M; Castell, JV; Donato, MT; García-Mediavilla, MV; Guzmán, C; Jover, R; Martínez-Chantar, ML; Pisonero-Vaquero, S; Sánchez-Campos, S | 1 |
Fromenty, B; Lettéron, P; Mansouri, A; Pessayre, D; Sutton, A | 1 |
Deschamps, D; Freneaux, E; Fromenty, B; Labbe, G; Larrey, D; Letteron, P; Pessayre, D | 1 |
3 other study(ies) available for tianeptine and Fatty Liver
Article | Year |
---|---|
Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease.
Topics: Animals; CCAAT-Enhancer-Binding Protein-alpha; Cells, Cultured; Cyclosporine; Doxycycline; Fatty Liver; Humans; Male; Mice; Mitogen-Activated Protein Kinase 1; Non-alcoholic Fatty Liver Disease; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Tetracycline; Thiazepines; Transcription, Genetic; Valproic Acid | 2015 |
Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
Topics: Amiodarone; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Apolipoproteins B; Carrier Proteins; Dibenzocycloheptenes; Doxycycline; Enzyme Inhibitors; Fatty Liver; Lipoproteins, VLDL; Mice; Microsomes, Liver; Mitochondria, Liver; Oxidation-Reduction; Phenylpropionates; Sonication; Tetracycline; Thiazepines; Triglycerides | 2003 |
Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Blood Glucose; Fatty Acids; Fatty Liver; Heptanoic Acids; Ketone Bodies; Male; Mice; Mitochondria, Liver; Molecular Structure; Oxidation-Reduction; Thiazepines; Time Factors; Triglycerides | 1989 |